Medical Director Articles

The term "article" is used to describe any bulletin article, web site article, educational handout or any other non-LCD document intended for public release that contains coverage/coding statements or medical review related billing or claims considerations.

Articles address local coverage, coding or medical review related billing and claims considerations, and may include any newly developed educational materials, coding instructions or clarification of existing medical review related billing or claims policy.

The article listing will continue to expand as additions are made.

Last Updated Jan 30 , 2024
Articles Source Posted
Billing and Coding Investigational Device Exemptions (IDE) - IDE Documentation Requirements for Studies with an FDA Approval dated January 01, 2015, or later (A54919) - R8 - Effective October 1, 2015 Jul 03, 2025
2025 Q3 MolDX CPT/HCPCS Billing and Coding Article Updates - Effective July 1, 2025 Jul 03, 2025
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R26 - Effective July 1, 2025 Jul 03, 2025
Billing and Coding: MolDX: Pharmacogenomics Testing (A57384) - R16 - Effective July 1, 2025 Jul 03, 2025
MolDX: Breast Cancer Index (BCI) Gene Expression Test (L37822) - R5 - Effective July 3, 2025 Jul 03, 2025
MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (L39005) - R2 - Effective July 3, 2025 Jul 03, 2025
MolDX: Pharmacogenomics Testing (L38335) - R2 - Effective July 3, 2025 Jul 03, 2025
MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells (L38643) - R2 - Effective July 3, 2025 Jul 03, 2025
MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer (L38327) - R3 - Effective July 3, 2025 Jul 03, 2025
MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer (L38647) - R2 - Effective July 3, 2025 Jul 03, 2025